Health and Fitness Health and Fitness
Thu, January 15, 2009
Wed, January 14, 2009
Tue, January 13, 2009
Mon, January 12, 2009
Sun, January 11, 2009
Fri, January 9, 2009
Thu, January 8, 2009
Wed, January 7, 2009
Tue, January 6, 2009
Mon, January 5, 2009
[ Mon, Jan 05th 2009 ] - Market Wire
Avexa and Progen Merger Update
Fri, January 2, 2009
Thu, January 1, 2009
Wed, December 31, 2008
[ Wed, Dec 31st 2008 ] - Market Wire
Obesity Comes With a Price Tag
Tue, December 30, 2008
Mon, December 29, 2008
Wed, December 24, 2008
Tue, December 23, 2008

Teva to Present at the 27th Annual J.P. Morgan Healthcare Conference


//health-fitness.news-articles.net/content/2009/ .. 7th-annual-j-p-morgan-healthcare-conference.html
Published in Health and Fitness on Thursday, January 8th 2009 at 7:55 GMT, Last Modified on 2009-01-08 07:56:20 by Market Wire   Print publication without navigation


JERUSALEM--([ BUSINESS WIRE ])--Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) will host a live audio webcast at the 27th Annual J.P. Morgan Healthcare Conference in San Francisco, CA. Eyal Desheh, Chief Financial Officer and William Marth, President and CEO, Teva North America, will present on Monday, January 12, 2009.

What:

  Teva Presentation at the J.P. Morgan Annual Healthcare Conference in San Francisco, CA.
 

Who:

Eyal Desheh, Chief Financial Officer
William Marth, President and CEO, Teva North America
 

When:

Monday, January 12, 2009 11 a.m. PT
 

Where:

[ www.tevapharm.com ] or

[ http://metameetings.com/webcasts/jpmorgan/healthcare09/directlink?ticker=TEVA ]

 

How:

Live over the Internet -- log on to the Web at the address above and register for the event (approx. 10 minutes before). An archive of the webcast will be available on Teva's website.

About Teva

Teva Pharmaceutical Industries Ltd., headquartered in Israel, is among the top 20 pharmaceutical companies in the world and is the leading generic pharmaceutical company. The company develops, manufactures and markets generic and innovative pharmaceuticals and active pharmaceutical ingredients. Over 80 percent of Teva's sales are in North America and Western Europe.


Publication Contributing Sources